{"id":"https://openalex.org/W4308399172","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","title":"848 Impact of immunotherapy time-of-day infusion on overall survival in patients with metastatic renal cell carcinoma","display_name":"848 Impact of immunotherapy time-of-day infusion on overall survival in patients with metastatic renal cell carcinoma","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308399172","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0848"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0848","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A886.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A886.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101543448","display_name":"Jimmy S. Patel","orcid":"https://orcid.org/0000-0002-7322-7578","observed_orcids":["https://orcid.org/0000-0002-7322-7578"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jimmy Patel","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043656268","display_name":"Amber Draper","orcid":"https://orcid.org/0000-0001-7172-205X","observed_orcids":["https://orcid.org/0000-0001-7172-205X"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber Draper","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069132199","display_name":"Yena Woo","orcid":"https://orcid.org/0000-0002-5853-9004","observed_orcids":["https://orcid.org/0000-0002-5853-9004"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yena Woo","raw_affiliation_strings":["Emory University, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080667772","display_name":"Layla Dhabaan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Layla Dhabaan","raw_affiliation_strings":["Emory University, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024852113","display_name":"Pretesh R Patel","orcid":"https://orcid.org/0000-0002-3522-1204","observed_orcids":["https://orcid.org/0000-0002-3522-1204"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pretesh Patel","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112746616","display_name":"Ashesh B. Jani","orcid":"https://orcid.org/0000-0002-1687-6221","observed_orcids":["https://orcid.org/0000-0002-1687-6221"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashesh Jani","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035665916","display_name":"Bradley Curtis Carthon","orcid":"https://orcid.org/0000-0002-9176-8538","observed_orcids":["https://orcid.org/0000-0002-9176-8538"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Carthon","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013832255","display_name":"Viraj A. Master","orcid":"https://orcid.org/0000-0002-7251-142X","observed_orcids":["https://orcid.org/0000-0002-7251-142X"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viraj Master","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066327728","display_name":"Haydn Thomas Kissick","orcid":"https://orcid.org/0000-0001-7624-5598","observed_orcids":["https://orcid.org/0000-0001-7624-5598"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haydn Kissick","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049071296","display_name":"Mehmet As\u0131m Bilen","orcid":"https://orcid.org/0000-0003-4003-1103","observed_orcids":["https://orcid.org/0000-0003-4003-1103"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Bilen","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020063441","display_name":"Zachary S. Buchwald","orcid":"https://orcid.org/0000-0003-4407-7264","observed_orcids":["https://orcid.org/0000-0003-4407-7264"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Buchwald","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":null,"display_name":"David Qian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Qian","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta, GA, United States","institution_ids":["https://openalex.org/I4390039307"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A886","last_page":"A886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6104000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6104000210762024,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.37959998846054077,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/circadian-rhythm","display_name":"circadian rhythm","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9097660779953003},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8877881169319153},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.8173164129257202},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.7700773477554321},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7081719636917114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5466747879981995},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5317893028259277},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4406319260597229},{"id":"https://openalex.org/C2780227381","wikidata":"https://www.wikidata.org/wiki/Q1357376","display_name":"Nephrectomy","level":3,"score":0.43433690071105957},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.42650073766708374},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4101765751838684},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4073387086391449},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3915106952190399},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3648456335067749},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3630256652832031},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.1999148428440094},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0848","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A886.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0848","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0848","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A886.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308399172.pdf","grobid_xml":"https://content.openalex.org/works/W4308399172.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393230843","https://openalex.org/W4399394243","https://openalex.org/W4324136242","https://openalex.org/W7205001644","https://openalex.org/W7162486624","https://openalex.org/W4324136506","https://openalex.org/W4381953379","https://openalex.org/W4286296224","https://openalex.org/W4405423325","https://openalex.org/W7203727006"],"abstract_inverted_index":{"Background":[0],"Our":[1,231],"prior":[2,94],"study":[3],"demonstrated":[4],"that":[5,40],"the":[6,41,140,181],"time-of-day":[7,42,228],"of":[8,43,62,90,132,142,155,176,199,212,238],"immune":[9],"checkpoint":[10],"inhibitor":[11],"(ICI)":[12],"infusion":[13,45],"influences":[14],"clinical":[15],"outcomes":[16],"including":[17],"overall":[18],"survival":[19],"(OS)":[20],"for":[21,49],"Stage":[22],"IV":[23,53,67,119],"melanoma":[24,248],"patients.":[25],"Similar":[26],"results":[27],"have":[28],"subsequently":[29],"been":[30],"shown":[31],"in":[32,180,247],"lung":[33,250],"cancer.":[34,251],"In":[35,110],"this":[36,111],"study,":[37,112],"we":[38],"hypothesized":[39],"ICI":[44,71,91,144,152,178,229],"may":[46,224],"impact":[47],"OS":[48,87,186],"patients":[50,64,116,168],"with":[51,65,117,221,235,243],"stage":[52,66,118],"renal":[54],"cell":[55],"carcinoma":[56],"(RCC).":[57],"Methods":[58],"The":[59,166],"treatment":[60,145],"records":[61],"all":[63],"RCC":[68,120,202,223],"who":[69,123,170],"underwent":[70],"therapy":[72],"within":[73],"a":[74,130,174],"multi-center":[75],"academic":[76],"hospital":[77],"system":[78],"between":[79,86],"2015":[80],"and":[81,88,127,160,205,210,249],"2020":[82],"were":[83,114,124],"reviewed.":[84],"Association":[85],"proportion":[89],"infusions":[92,179],"received":[93,171],"to":[95,98],"13:00":[96],"(cutoff":[97],"denote":[99],"morning":[100,182],"infusions)":[101],"was":[102,146],"evaluated":[103],"using":[104],"Cox":[105],"proportional":[106],"hazards":[107],"regression.":[108],"Results":[109],"there":[113],"201":[115],"(28%":[121],"female)":[122],"administered":[125],"ICIs":[126],"followed":[128],"over":[129],"median":[131],"18":[133],"months":[134],"(IQR":[135,149],"5\u201330).":[136],"Median":[137],"age":[138],"at":[139,172],"time":[141],"starting":[143],"63":[147],"years":[148],"56\u201370).":[150],"Initial":[151],"agents":[153],"consisted":[154],"pembrolizumab":[156],"(8%),":[157],"nivolumab":[158],"(61%),":[159],"dual":[161],"nivolumab/ipilimumab":[162],"(31%);":[163],"table":[164,215],"1.":[165,218],"119":[167],"(59%)":[169],"least":[173],"quarter":[175],"their":[177],"had":[183],"significantly":[184],"longer":[185],"(median":[187],"58":[188],"vs.":[189],"34":[190],"months,":[191],"HR":[192],"0.51,":[193],"95%":[194],"CI":[195],"0.29\u20130.89,":[196],"P=0.017),":[197],"independent":[198],"age,":[200],"sex,":[201],"histology,":[203],"liver":[204],"brain":[206],"metastases,":[207],"pre-treatment":[208],"LDH,":[209],"choice":[211],"initial":[213],"ICI;":[214],"2,":[216],"figure":[217],"Conclusions":[219],"Patients":[220],"metastatic":[222],"benefit":[225],"from":[226],"earlier":[227],"infusions.":[230],"findings":[232],"are":[233,256],"consistent":[234],"established":[236],"mechanisms":[237],"chrono-immunology,":[239],"as":[240,242],"well":[241],"preceding":[244],"analogous":[245],"studies":[246],"Additional":[252],"prospective":[253],"randomized":[254],"trials":[255],"warranted.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-11T00:00:00"}